Heron Therapeutics, Inc. · NASDAQ:HRTX

Clearline Capital LP reported a 5.30% stake in Heron Therapeutics, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 26, 2025

Clearline Capital LP reported a 5.30% stake in Heron Therapeutics, Inc., 9,712,527 shares, as a passive investor on Sep 30, 2025. Filed Nov 26, 2025 (Schedule 13G).

Stake
5.30%
Shares
9,712,527
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Clearline Capital LP5.30%9,712,527
Clearline Capital LLC5.30%9,712,527
Marc Majzner5.30%9,712,527

Source

View original at SEC

Related